Actively building life science companies

5AM Ventures is a leading venture capital firm focused on building next-generation life science companies capable of delivering outstanding returns to our investors.

Scroll to experience 5AM Ventures

Supporting companies that are working to solve important healthcare needs via cutting-edge breakthroughs in medicine and science.

Read Me

IDEAYA Announces Dosing of First Patient of MAT2A Inhibitor IDE397 in Phase 1 Clinical Trial Evaluating MTAP-Deletion Solid Tumors
Read Me

Scientist.com Recognized as One of The America’s Fastest Growing Companies by The Financial Times
Read Me

Marvin, Halio Inc. Announce Exclusive Agreement to Bring Halio® Smart Glass to Residential Market
Read Me

Kinestral Technologies, Inc. Announces Widely-Recognized Halio Product Name as New Corporate Identity
Read Me

Akouos Receives Orphan Drug and Rare Pediatric Disease Designations for AK-OTOF for the Treatment of Otoferlin Gene-Mediated Hearing Loss

Pushing the healthcare industry forward

$ 0 B

UNDER MANAGEMENT

We’re a life science venture capital firm founded in 2002 and currently investing $350M from 5AM Ventures VI and $147M from 5AM Opportunities I.
0

PORTFOLIO COMPANIES

Our focus is biopharmaceuticals, drug delivery technologies and life science instruments.
0

ONGOING CLINICAL TRIALS

Our portfolio companies currently have over 18,000 patients enrolled across 750 test sites in ongoing clinical trials.

San Francisco, CA

Boston, MA

San Francisco

501 Second Street
Suite 350
San Francisco, CA 94107

Tel: 415-993-8570
Boston

200 Clarendon Street
45th Floor
Boston, MA 02116

Tel: 857-305-1825

© 2021 5AM Venture Management LLC